LYC Healthcare Berhad Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda LYC Healthcare Berhad için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

IT kazanç büyümesi	13.8%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Sep 20

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 14

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jul 04

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Mar 26

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Feb 01

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Sep 15

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

Sep 10

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

May 11

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Nov 29

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jun 13

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Mar 01

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak LYC Healthcare Berhad yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

KLSE:LYC - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (MYR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
6/30/2024	143	-20	4	7	N/A
3/31/2024	130	-19	3	9	N/A
12/31/2023	121	-17	-11	-4	N/A
9/30/2023	108	-17	-4	2	N/A
6/30/2023	98	-17	-7	0	N/A
3/31/2023	92	-19	2	5	N/A
12/31/2022	86	-12	21	19	N/A
9/30/2022	84	-12	3	5	N/A
6/30/2022	74	-11	-1	2	N/A
3/31/2022	65	-9	-3	0	N/A
12/31/2021	58	-11	-10	-3	N/A
9/30/2021	44	-12	-4	-1	N/A
6/30/2021	35	-12	-2	1	N/A
3/31/2021	26	-12	-6	-2	N/A
12/31/2020	16	-14	-8	3	N/A
9/30/2020	13	-12	-10	0	N/A
6/30/2020	12	-11	-12	-1	N/A
3/31/2020	12	-10	-12	-1	N/A
12/31/2019	12	-8	-11	-7	N/A
9/30/2019	10	-8	-8	-4	N/A
6/30/2019	6	-8	-7	-4	N/A
3/31/2019	8	-8	-7	-4	N/A
12/31/2018	6	-7	-9	-1	N/A
9/30/2018	6	-6	-11	-3	N/A
6/30/2018	7	-4	-10	-3	N/A
3/31/2018	6	-3	N/A	-2	N/A
3/31/2017	33	-2	N/A	-2	N/A
9/30/2016	35	-1	N/A	-4	N/A
6/30/2016	39	-1	N/A	-1	N/A
3/31/2016	42	-2	N/A	-1	N/A
12/31/2015	40	-2	N/A	-3	N/A
9/30/2015	40	-2	N/A	0	N/A
6/30/2015	43	0	N/A	-3	N/A
3/31/2015	44	0	N/A	-1	N/A
12/31/2014	43	-1	N/A	-1	N/A
9/30/2014	41	-2	N/A	-3	N/A
6/30/2014	33	-3	N/A	-4	N/A
3/31/2014	32	-3	N/A	-5	N/A
12/31/2013	33	-3	N/A	-2	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: LYC 'un tahmini kazanç büyümesinin tasarruf oranının ( 3.6% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: LYC 'un kazançlarının MY pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: LYC şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: LYC şirketinin gelirinin MY pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: LYC şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: LYC 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

LYC Healthcare Berhad Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

LYC Healthcare Berhad Appoints Kong Sin Seng as Independent and Non Executive Chairman of Audit Committee

Wong Chew Weng agreed to acquire an additional 55% stake in Elite Dental Team Sdn Bhd from LYC Healthcare Berhad (KLSE:LYC) for MYR 6.5 million.

LYC Healthcare Berhad Approves Audit Committee Be Changed to Audit and Risk Management Committee, Effective September 28, 2024

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Take Care Before Diving Into The Deep End On LYC Healthcare Berhad (KLSE:LYC)

Full year 2024 earnings released: RM0.029 loss per share (vs RM0.035 loss in FY 2023)

LYC Healthcare Berhad, Annual General Meeting, Sep 27, 2024

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2024 earnings released: RM0.03 loss per share (vs RM0.035 loss in FY 2023)

New minor risk - Share price stability

LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer

Third quarter 2024 earnings released: RM0.006 loss per share (vs RM0.007 loss in 3Q 2023)

LYC Healthcare Berhad Announces Resignation of Mr. Cheah SEK Hon as Chief Financial Officer , Effective from 28 April 2024

LYC Healthcare Berhad Announces Resignation of Encik Ahmad Rafique Bin Mat Tahir as Chief Operating Officer, Effective 19 February.2024

Second quarter 2024 earnings released: RM0.006 loss per share (vs RM0.009 loss in 2Q 2023)

LYC Healthcare Berhad has filed a Follow-on Equity Offering in the amount of MYR 12.804571 million.

New minor risk - Share price stability

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad, Annual General Meeting, Sep 21, 2023

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad Appoints Poh Zuan Yin as Independent and Non Executive Member of Audit Committee

LYC Healthcare Berhad (KLSE:LYC) acquired 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei.

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Third quarter 2023 earnings released: RM0.007 loss per share (vs RM0.007 loss in 3Q 2022)

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.007 loss in 2Q 2022)

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

LYC Healthcare Berhad announced a financing transaction

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.033 loss in FY 2021)

LYC Healthcare Berhad, Annual General Meeting, Sep 22, 2022

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad Announces Appointment of Mr. Cheah SEK Hon as Chief Financial Officer

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

LYC Healthcare Berhad (KLSE:LYC) agreed to acquire Tao Global Ventures Sdn Bhd from Dinesh A/L Kanasen and Sarahanna A/P Selvarajah for RMB 4 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings released: RM0.033 loss per share (vs RM0.029 loss in FY 2020)

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2021 earnings released: RM0.032 loss per share (vs RM0.029 loss in FY 2020)

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Third quarter 2021 earnings released: RM0.013 loss per share (vs RM0.006 loss in 3Q 2020)

Non-Independent Non-Executive Director has left the company

LYC Healthcare Berhad Announces Resignation of Josephie Sui Sze Pin as Non Independent and Non Executive Member of Remuneration Committee

New 90-day low: RM0.25

New 90-day low: RM0.29

New 90-day low: RM0.30

New 90-day low: RM0.32

Second quarter 2021 earnings released: RM0.008 loss per share

LYC Healthcare Berhad (KLSE:LYC) acquired remaining 49% stake in LYC Cosmetic & Aesthetic Sdn Bhd from Xing Dao International Pte. Ltd for MYR 0.05 million.

New 90-day low: RM0.33

First quarter earnings released

First quarter earnings released

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin